South Korea Connected Drug Delivery Devices Market Insight
Published: 02 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The market for connected drug delivery devices in South Korea is expected to grow at a strong CAGR of 10.09% thanks to digital health and chronic illness management.
South Korea Connected Drug Delivery Devices Market Insights Forecasts to 2035
- The South Korea Connected Drug Delivery Devices Market Size Was Estimated USD 294.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 10.09% from 2025 to 2035
- The South Korea Connected Drug Delivery Devices Market Size is Expected to rise around USD 770.4 Million by 2035
Notable Insights for the South Korea Connected Drug Delivery Devices Market
- Standalone parts and software are in the lead based on product category segmentation, however integrated devices are expanding quickly for chronic care applications.
- In terms of method of administration segmentation, the fastest-growing category is inhalational, while parenteral accounts for around 56% of the market.
- The government of South Korea is investing a lot of money. KRW 1.2 trillion. In medical technology from 2025 to 2032.
- The bigger market for medication delivery devices in South Korea was worth USD 5.08 billion in 2025. Is growing at a rate of 8.47%.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Cutting-Edge Connected Health & Drug Delivery Insights
Decision Advisors delivers sophisticated research on networked drug delivery devices, comprising smart inhalers, connected pens, and wearables injectors in South Korea. Opportunities in Diabetes, Respiratory, and Chronic Disease Management have been highlighted.
- Robust Research Methodology with Accurate Forecasting Models
This analysis is comprised of interviews with technology providers, healthcare experts, and digital health experts, alongside secondary analysis through healthcare databases, regulations, and industry reports. This approach enables accurate market estimation and technology adoption analysis.
- Comprehensive Competitive and Ecosystem Analysis
The report evaluates the key vendors of connectivity-enabled drug delivery systems, electronically-powered infusion pumps, and smart injection systems. It discusses the competitive positioning, strategic collaborations, and regulations that define the connected health market space in South Korea.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea connected drug delivery devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Connected Drug Delivery Devices Market
- EOFlow Co., Ltd.
- LG Chem
- Yuhan Corporation
- Daewon Pharmaceutical Co., Ltd.
- Dongkook Pharmaceutical Co., Ltd.
- TDS Pharm
- QuadMedicine Co., Ltd.
- Icure Pharmaceutical Inc.
- RecensMedical, Inc.
- Samsung Electronics (Healthcare Division)
Recent Developments:
- In February 2026, TDS Pharm introduced a smart transdermal drug delivery system that helps patients take their medicine correctly.
- In October 2025, Yuhan Corporation worked with healthcare companies to improve how patients take their medicine and engage with their healthcare.
Market Segmentation:
South Korea Connected Drug Delivery Devices Market, By Product Type
- Standalone Components & Software
- Integrated Devices (Smart Inhalers, Connected Pens, Wearable Injectors)
South Korea Connected Drug Delivery Devices Market, By Route of Administration
-
- Parenteral (Injectable)
- Inhalational
South Korea Connected Drug Delivery Devices Market, By Application
-
- Diabetes Management
- Asthma & COPD
- Cardiovascular Disorders
- Others (Oncology, Autoimmune)
Expert Views:
The South Korea connected drug delivery devices market stands to see continued growth driven by increased uptake of digital health care solutions, prevalence of chronic diseases, and investment by the government in advanced medical technologies. Innovation in the area of connected therapies, artificial intelligence, and integration of health care systems will enhance patient care and medication compliance while creating major business opportunities in the process.
Author: Govind and Krishna By Decisions Advisors and Consulting